Clinical and laboratory features of scleroderma patients with pulmonary hypertension

被引:53
作者
Yamane, K [1 ]
Ihn, H [1 ]
Asano, Y [1 ]
Yazawa, N [1 ]
Kubo, M [1 ]
Kikuchi, K [1 ]
Soma, Y [1 ]
Tamaki, K [1 ]
机构
[1] Univ Tokyo, Fac Med, Dept Dermatol, Bunkyo Ku, Tokyo 1138655, Japan
关键词
pulmonary hypertension; scleroderma; Doppler echocardiography;
D O I
10.1093/rheumatology/39.11.1269
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Pulmonary hypertension (PH) is a frequent cause of death in patients with systemic sclerosis (SSc). In this study, we examined the occurrence of PH and investigated the clinical and laboratory features of SSc patients with PH. Methods. A cross-sectional study of 125 Japanese patients with SSc was conducted using Doppler echocardiography, other multiple cardiopulmonary tests, and laboratory examination. Results. PH (systolic pressure >40 mmHg) was diagnosed in 20 patients (16%) by Doppler echocardiography. In the six patients who had secondary pulmonary hypertension (SPH), PH was due to severe pulmonary fibrosis; 14 patients had isolated pulmonary hypertension (IPH). An elevated erythrocyte sedimentation rate (ESR) and increased immunoglobulin G (IgG) were found in a significantly greater proportion of the patients with PK than in those without PH. The incidence of pitting scars/ulcers was significantly greater in the patients with SPH than in those without PH. Conclusion. Elevated ESR and increased IgG were common features of scleroderma patients with PH, and scleroderma patients with SPH were inclined to have pitting scars/ulcers.
引用
收藏
页码:1269 / 1271
页数:3
相关论文
共 14 条
[1]   PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
不详 .
ARTHRITIS AND RHEUMATISM, 1980, 23 (05) :581-590
[2]   Prevalence of pulmonary hypertension in limited and diffuse scleroderma [J].
Battle, RW ;
Davitt, MA ;
Cooper, SM ;
Buckley, LM ;
Leib, ES ;
Beglin, PA ;
Tischler, MD .
CHEST, 1996, 110 (06) :1515-1519
[3]  
Ihn H, 1998, BRIT J RHEUMATOL, V37, P1188
[4]   Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension [J].
Kharitonov, SA ;
Cailes, JB ;
Black, CM ;
duBois, RM ;
Barnes, PJ .
THORAX, 1997, 52 (12) :1051-1055
[5]  
Koh ET, 1996, BRIT J RHEUMATOL, V35, P989
[6]  
LEROY EC, 1988, J RHEUMATOL, V15, P202
[7]   A BRIEF OVERVIEW OF THE PATHOGENESIS OF SCLERODERMA (SYSTEMIC-SCLEROSIS) [J].
LEROY, EC .
ANNALS OF THE RHEUMATIC DISEASES, 1992, 51 (02) :286-288
[8]   Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders - A Doppler echocardiographic study of 135 Japanese patients [J].
Murata, I ;
Takenaka, K ;
Yoshinoya, S ;
Kikuchi, K ;
Kiuchi, T ;
Tanigawa, T ;
Ito, K .
CHEST, 1997, 111 (01) :36-43
[9]  
Negi VS, 1998, J RHEUMATOL, V25, P462
[10]   SKIN THICKNESS AND COLLAGEN CONTENT IN PROGRESSIVE SYSTEMIC-SCLEROSIS AND LOCALIZED SCLERODERMA [J].
RODNAN, GP ;
LIPINSKI, E ;
LUKSICK, J .
ARTHRITIS AND RHEUMATISM, 1979, 22 (02) :130-140